Increased Microvessel and Arteriole Density in the Contracted Side of the Relapsed Clubfoot
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články
PubMed
32379245
DOI
10.1097/bpo.0000000000001563
PII: 01241398-202011000-00017
Knihovny.cz E-zdroje
- MeSH
- arterioly * MeSH
- beta-katenin metabolismus MeSH
- lidé MeSH
- patologická angiogeneze * MeSH
- pes equinovarus etiologie metabolismus terapie MeSH
- předškolní dítě MeSH
- prospektivní studie MeSH
- receptor 2 pro vaskulární endoteliální růstový faktor metabolismus MeSH
- recidiva MeSH
- sádrové obvazy MeSH
- vaskulární endoteliální růstový faktor A metabolismus MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- beta-katenin MeSH
- CTNNB1 protein, human MeSH Prohlížeč
- KDR protein, human MeSH Prohlížeč
- receptor 2 pro vaskulární endoteliální růstový faktor MeSH
- vaskulární endoteliální růstový faktor A MeSH
- VEGFA protein, human MeSH Prohlížeč
BACKGROUND: Clubfoot deformity (pes equinovarus) is one of the most common birth defects, and its etiology is still unknown. Initial clubfoot treatment is based on the Ponseti method throughout most of the world. Despite the effectiveness of this therapy, clubfoot may relapse. Recent studies confirm the theory of active fibrotic remodeling processes in the extracellular matrix of the affected tissue. The aim of this study was to clarify whether relapses in clubfoot therapy are associated with altered angiogenesis and to suggest possible regulatory pathways of this pathologic process. METHODS: We compared microvessel density, arteriole density, and concentration of angioproliferative-related proteins found between tissues in the contracted, that is, the medial side (M-side), and noncontracted, that is, the lateral side (L-side) of the relapsed clubfeet. Tissue samples from 10 patients were analyzed. Histopathologic analysis consisted of immunohistochemistry and image analysis. Real-time polymerase chain reaction was used to study mRNA expression. RESULTS: An increase in microvessel and arteriole density was noted in contracted, relapsed clubfoot tissue. This was accompanied by a significant increase in the levels of the vascular endothelial growth factor, vascular endothelial growth factor receptor 2, β catenin and active β catenin. Vascular endothelial growth factor, vascular endothelial growth factor receptor 2, and CD31 overexpression was also seen with mRNA analysis. CONCLUSIONS: Increased microvessel and arteriole density in the contracted side of the relapsed clubfoot was noted. These processes are mediated by specific proangiogenic proteins that are overexpressed in the contracted tissue. These findings contribute to the etiology and the development of relapses in the treatment of clubfoot. LEVEL OF EVIDENCE: Level II-analytical and prospective.
2nd Faculty of Medicine Charles University
Department of Orthopaedics Masaryk Hospital
Department of Orthopaedics University Hospital Bulovka Charles University Prague Czech Republic
Faculty of Health Studies Jan Evangelista Purkyne University Usti nad Labem
Zobrazit více v PubMed
Poon R, Li C, Alman BA. Beta-catenin mediates soft tissue contracture in clubfoot. Clin Orthop Relat Res. 2009;467:1180–1185.
Pavone V, Chisari E, Vescio A, et al. The etiology of idiopathic congenital talipes equinovarus: a systematic review. J Orthop Surg Res. 2018;13:206–216.
Dobbs MB, Gurnett CA. Update on clubfoot: etiology and treatment. Clin Orthop Relat Res. 2009;467:1146–1153.
Shabtai L, Specht SC, Herzenberg JE. Worldwide spread of the Ponseti method for clubfoot. World J Orthop. 2014;5:585–590.
Ostadal M, Liskova J, Hadraba D, et al. Possible pathogenetic mechanisms and new therapeutic approaches of pes equinovarus. Physiol Res. 2017;66:403–410.
Eckhardt A, Novotny T, Doubkova M, et al. Novel contribution to clubfoot pathogenesis: the possible role of extracellular matrix proteins. J Orthop Res. 2019;37:769–778.
Kerling A, Stoltenburg-Didinger G, Grams L, et al. The congenital clubfoot—immunohistological analysis of the extracellular matrix. Orthop Res Rev. 2018;10:55–62.
Holzer LA, Cor A, Pfandlsteiner G, et al. Expression of VEGF, its receptors, and HIF-1alpha in Dupuytren’s disease. Acta Orthop. 2013;84:420–425.
Ponseti IV. Treatment of congenital club foot. J Bone Joint Surg Am. 1992;74:448–454.
Thelin MA, Bartolini B, Axelsson J, et al. Biological functions of iduronic acid in chondroitin/dermatan sulfate. FEBS J. 2013;280:2431–2446.
Xu Q, Wu N, Cui L, et al. The next hotspot in skeletal research? J Genet Genomics. 2017;44:335–342.
Maffulli N, Capasso G, Testa V, et al. Histochemistry of the triceps surae muscle in idiopathic congenital clubfoot. Foot Ankle. 1992;13:80–84.
Ponseti IV. Relapsing clubfoot: causes, prevention, and treatment. Iowa Orthop J. 2002;22:55–56.
Radler C. The Ponseti method for the treatment of congenital club foot: review of the current literature and treatment recommendations. Int Orthop. 2013;37:1747–1753.
Laaveg SJ, Ponseti IV. Long-term results of treatment of congenital club foot. J Bone Joint Surg Am. 1980;62:23–31.
Alves C, Escalda C, Fernandes P, et al. Ponseti method: does age at the beginning of treatment make a difference? Clin Orthop Relat Res. 2009;467:1271–1277.
Paulsen-Miller M, Dolan LA, Stineman A, et al. Understanding the educational needs for parents of children with clubfoot. Orthop Nurs. 2011;30:273–278; quiz 9–80.
Nishisho T, Yukata K, Matsui Y, et al. Angiogenesis and myogenesis in mouse tibialis anterior muscles during distraction osteogenesis: VEGF, its receptors, and myogenin genes expression. J Orthop Res. 2012;30:1767–1773.
Li C, Nguyen Q, Cole WG, et al. Potential treatment for clubfeet based on growth factor blockade. J Pediatr Orthop. 2001;21:372–377.
Schluter A, Weller P, Kanaan O, et al. CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma. BMC Cancer. 2018;18:272–279.
Folkman J. Angiogenesis. Ann Rev Med. 2006;57:1–18.
Rehman S, Goodacre R, Day PJ, et al. Dupuytren’s: a systems biology disease. Arthritis Res Ther. 2011;13:238–249.
Marien KM, Croons V, Waumans Y, et al. Development and validation of a histological method to measure microvessel density in whole-slide images of cancer tissue. PLoS One. 2016;11:e0161496.
Shiraki T, Aoyama T, Yokoyama C, et al. LOX-1 plays an important role in ischemia-induced angiogenesis of limbs. PLoS One. 2014;9:e114542.
Barratt SL, Flower VA, Pauling JD, et al. VEGF (vascular endothelial growth factor) and fibrotic lung disease. Int J Mol Sci. 2018;19:1269–1286.
Lam AP, Gottardi CJ. Beta-catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol. 2011;23:562–567.
Kim KI, Cho HJ, Hahn JY, et al. Beta-catenin overexpression augments angiogenesis and skeletal muscle regeneration through dual mechanism of vascular endothelial growth factor-mediated endothelial cell proliferation and progenitor cell mobilization. Arterioscler Thromb Vasc Biol. 2006;26:91–98.
Cao H, Wang C, Chen X, et al. Inhibition of Wnt/beta-catenin signaling suppresses myofibroblast differentiation of lung resident mesenchymal stem cells and pulmonary fibrosis. Sci Rep. 2018;8:13644–13657.
The possible role of hypoxia in the affected tissue of relapsed clubfoot